Pengfei Sun

677 total citations
24 papers, 328 citations indexed

About

Pengfei Sun is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Pengfei Sun has authored 24 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Pengfei Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Pengfei Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (4 papers). Pengfei Sun collaborates with scholars based in China, Hong Kong and Germany. Pengfei Sun's co-authors include Lei Li, Chengsheng Zhang, Zhongchao Li, Wuyuan Zhou, Xuetao Shi, Jingtao Zhong, Lei Li, Xiaofeng Dong, Kai Cui and Yao Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Science Advances.

In The Last Decade

Pengfei Sun

23 papers receiving 327 citations

Peers

Pengfei Sun
Chun‐Hua Wang China
Jieying Yang China
Xiaojie Gan China
Sampa Ghose India
Atsutaka Masuda Japan
Judit López‐Luque Spain
Wei Wen China
Yunxiuxiu Xu China
Yongpeng Wei China
Chun‐Hua Wang China
Pengfei Sun
Citations per year, relative to Pengfei Sun Pengfei Sun (= 1×) peers Chun‐Hua Wang

Countries citing papers authored by Pengfei Sun

Since Specialization
Citations

This map shows the geographic impact of Pengfei Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengfei Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengfei Sun more than expected).

Fields of papers citing papers by Pengfei Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengfei Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengfei Sun. The network helps show where Pengfei Sun may publish in the future.

Co-authorship network of co-authors of Pengfei Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Pengfei Sun. A scholar is included among the top collaborators of Pengfei Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengfei Sun. Pengfei Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Zhongchao, Jing Liu, Jinbo Yue, et al.. (2024). Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial. Nature Communications. 15(1). 3260–3260. 17 indexed citations
2.
Zeng, Weizhi, Pengfei Sun, Rong Wang, & Wan‐Tong Li. (2024). A nonlocal diffusion model with free boundaries in a spatially heterogeneous environment. Discrete and Continuous Dynamical Systems - B. 30(4). 1249–1279.
3.
Zhang, Bo, Xuetao Shi, Zhongchao Li, et al.. (2023). Real-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients. BMC Cancer. 23(1). 465–465. 13 indexed citations
4.
Sun, Pengfei, et al.. (2023). The function of miRNAs in the process of kidney development. Non-coding RNA Research. 8(4). 593–601. 6 indexed citations
5.
Ying, Ao, Zhiwei Liao, Jie Zhang, et al.. (2023). Role of C-Terminal Phosphorylation of Lamin A in DNA Damage and Cellular Senescence. Cells. 12(4). 639–639. 8 indexed citations
6.
Sun, Pengfei, Zhongchao Li, & Bo Zhang. (2023). Characterization of disease-associated microbiota in hepatocellular carcinoma. Journal of Cancer Research and Therapeutics. 19(4). 881–891. 11 indexed citations
7.
Ji, Jingjing, Ziwei Yang, Rui Zhang, et al.. (2022). Delivery of Mir-196c-3p with NIR-II light-triggered gel attenuates cardiomyocyte ferroptosis in cardiac ischemia-reperfusion injury. Nanomedicine Nanotechnology Biology and Medicine. 47. 102618–102618. 13 indexed citations
8.
Li, Zhongchao, Lei Li, Jingtao Zhong, et al.. (2022). Regorafenib combined with PD-1 monoclonal antibody in the second-line setting for hepatocellular carcinoma (HCC): A retrospective, real-world study in China.. Journal of Clinical Oncology. 40(16_suppl). e16145–e16145. 2 indexed citations
9.
Sun, Pengfei, et al.. (2021). Identification of Hub Genes in Hemifacial Microsomia: Evidence From Bioinformatic Analysis. Journal of Craniofacial Surgery. 33(2). e145–e149. 5 indexed citations
10.
Dong, Xiaofeng, Peng Xiu, Jianrong Yang, et al.. (2020). Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity. 2020. 1–15. 16 indexed citations
11.
Zhou, Cheng, et al.. (2020). <p>PFND1 Predicts Poor Prognosis of Gastric Cancer and Promotes Cell Metastasis by Activating the Wnt/β-Catenin Pathway</p>. OncoTargets and Therapy. Volume 13. 3177–3186. 12 indexed citations
12.
Sun, Pengfei, Lei Li, & Zhongchao Li. (2020). RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells. BioMed Research International. 2020(1). 5691671–5691671. 13 indexed citations
13.
Liu, Feng, Fuhai Wang, Xiaofeng Dong, et al.. (2019). T7 peptide cytotoxicity in human hepatocellular carcinoma cells is mediated by suppression of autophagy. International Journal of Molecular Medicine. 44(2). 523–534. 11 indexed citations
14.
Ying, Ao, Jie Zhang, Zuojun Liu, et al.. (2019). Lamin A buffers CK2 kinase activity to modulate aging in a progeria mouse model.. Science Advances. 5(3). eaav5078–eaav5078. 23 indexed citations
15.
16.
Chen, Xiangyuan, et al.. (2018). Propofol Disrupts Aerobic Glycolysis in Colorectal Cancer Cells via Inactivation of the NMDAR-CAMKII-ERK Pathway. Cellular Physiology and Biochemistry. 46(2). 492–504. 24 indexed citations
17.
18.
He, Dongying, et al.. (2018). Targeting STAT3 restores BRAF inhibitor sensitivity through miR-759-3p in human cutaneous melanoma cells.. PubMed. 11(5). 2550–2560. 4 indexed citations
19.
Zhong, Jingtao, Xiaoming Yu, Xiaofeng Dong, et al.. (2018). Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells. Oncology Letters. 15(5). 7191–7199. 15 indexed citations
20.
Zhong, Jingtao, Xiaoming Yu, Xiaofeng Dong, et al.. (2018). Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1/2 signals. International Journal of Molecular Medicine. 41(5). 2893–2900. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun‐Hua Wang Breakdown of academic impact, for papers by Jieying Yang Breakdown of academic impact, for papers by Xiaojie Gan Breakdown of academic impact, for papers by Sampa Ghose Breakdown of academic impact, for papers by Atsutaka Masuda Breakdown of academic impact, for papers by Judit López‐Luque Breakdown of academic impact, for papers by Wei Wen Breakdown of academic impact, for papers by Yunxiuxiu Xu Breakdown of academic impact, for papers by Yongpeng Wei
Rankless by CCL
2026